Liquidia Corporation is a biopharmaceutical company focused on developing, manufacturing, and commercializing therapies for rare cardiopulmonary diseases. The company’s current portfolio centers on treatments for pulmonary arterial hypertension and pulmonary hypertension associated with interstitial lung disease, supported by its proprietary PRINT particle-engineering platform, which is designed to create precise drug particles for inhaled and other advanced delivery formats. Liquidia’s work spans product development, manufacturing, and commercialization, giving it a role across the full lifecycle of specialty respiratory medicines. Its marketed and investigational programs are aimed at patients with challenging respiratory and vascular conditions, positioning the company within the rare-disease and specialty pharmaceutical markets. Liquidia Corporation is headquartered in Morrisville, North Carolina.
Website419 Davis Drive
Morrisville, NC, 27560
United States
United Therapeutics' declines are real but they sit in ~32% of the business, tax-normalized earnings power is $1.05 billion. See why UTHR stock is a Buy now.
Liquidia's Yutrepia is gaining traction, but patent litigation, competition, rising costs and heavy product dependence cloud LQDA's outlook.
Liquidia's Yutrepia wins FDA Fast Track status for SSc-related Raynaud's, opening a potential new growth avenue for the lead drug.
Investors talking about LQDA also mention
| # | Name | Attention |
|---|---|---|
| 1 | United Therapeutics CorporationUTHR | 0%-0.01 |
| 2 | Movella Holdings Inc.MVLA | 0%0 |
| 3 | Insmed IncorporatedINSM | 0%new |
| 4 | Richardson Electronics, Ltd.RELL | 0%0 |
| 5 | Hinge Health Inc.HNGE | 0.01%+0 |
| 6 | VRNA - Verona Pharma plc | —— |
| 7 | Abivax SAABVX | 0.01%-0.01 |
| 8 | Eton Pharmaceuticals, Inc.ETON | 0%-0.01 |
| 9 | Ani Pharmaceuticals, Inc.ANIP | 0%new |
| 10 | Brookfield Business Corporation Class A Subordinate Voting SharesBBUC | 0%-0.01 |
What share of all stock conversation is about LQDA?
| 1 Day1D | 1 Week1W | 1 Month1M | 1 Year1Y | 50-Day MAclick to plot | 200-Day MAclick to plot | |
|---|---|---|---|---|---|---|
| Attention | 0.01% 0 | 0.01% +0 | 0.01% -0.01 | 0.01% +0 |
Of the messages about LQDA that take a side, what share is each?
| 1 Day1D | 1 Week1W | 1 Month1M | 1 Year1Y | 50-Day MAclick to plot | 200-Day MAclick to plot | |
|---|---|---|---|---|---|---|
| Bullish | 76.47% +13.61 | 47.09% -12.68 | 72.73% +4.17 | 76.67% +3.18 | ||
| Bearish | 23.53% -13.61 | 52.91% +12.68 | 27.27% -4.17 | 23.33% -3.18 |
Of the messages about LQDA that carry a topic, what share is each?
| 1 Day1D | 1 Week1W | 1 Month1M | 1 Year1Y | 50-Day MAclick to plot | 200-Day MAclick to plot | |
|---|---|---|---|---|---|---|
| Announcements | 0% | 38.68% | 60.15% | 40.81% | ||
| Technical Analysis | 100% | 9.43% | 12.69% | 12.21% | ||
| Controversies | 0% | 0% | 12.69% | 18.43% | ||
| Analysts | 0% | 51.89% | 14.47% | 9.04% | ||
| Earnings | 0% | 0% | 0% | 19.13% | ||
| Macro | 0% | 0% | 0% | 0.39% |
Of the messages about LQDA, what share comes from each group?
| 1 Day1D | 1 Week1W | 1 Month1M | 1 Year1Y | 50-Day MAclick to plot | 200-Day MAclick to plot | |
|---|---|---|---|---|---|---|
| Regulars | 94.12% | 84.64% | 84.75% | 80.48% | ||
| Newcomers | 5.88% | 15.36% | 15.25% | 19.52% |